N
STTK icon

Nuveen’s Shattuck Labs STTK Stock Holding History

Nuveen’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-53,038
Closed -$50.4K – 3408
2025
Q1 		$50.4K Hold
53,038
– – ﹤0.01% 3259
2024
Q4 		$64.2K Hold
53,038
– – ﹤0.01% 3310
2024
Q3 		$185K Hold
53,038
– – ﹤0.01% 3238
2024
Q2 		$205K Buy
+53,038
New +$431K ﹤0.01% 3211
2022
Q2 		– Sell
-71,566
Closed -$346K – 3468
2022
Q1 		$346K Sell
71,566
-31,455
-31% -$178K ﹤0.01% 3095
2021
Q4 		$877K Sell
103,021
-2,010
-2% -$27.7K ﹤0.01% 2898
2021
Q3 		$2.14M Buy
105,031
+4,125
+4% +$88.3K ﹤0.01% 2642
2021
Q2 		$2.93M Buy
100,906
+44,493
+79% +$1.3M ﹤0.01% 2533
2021
Q1 		$1.65M Buy
56,413
+1,209
+2% +$50.8K ﹤0.01% 2702
2020
Q4 		$2.89M Buy
+55,204
New +$1.77M ﹤0.01% 2323

Other funds holding STTK

PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return

Nuveen's STTK Position: Q2 2025 in Review

Nuveen sold out of Shattuck Labs (STTK) in Q2 2025, closing a stake of 53,038 shares — an estimated $50.4K sold.

Nuveen first reported a position in STTK in Q4 2020 and held it in 10 quarters. The position peaked at $2.93M in Q2 2021. 61 funds tracked by Wall St. Rank hold STTK as of Q2 2025.

  • Nuveen reported no remaining Shattuck Labs position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 53,038 Shattuck Labs shares in Q2 2025, an estimated $50.4K.
  • Nuveen first reported a position in Shattuck Labs in Q4 2020 and held it in 10 quarters.
  • Nuveen's Shattuck Labs position peaked at $2.93M in Q2 2021.
  • 61 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.